Tournament: Loyola | Round: 1 | Opponent: Marlborough AW | Judge: Gordon Krauss
Covid-19 has supercharged innovation in the status quo
Ramalingam and Prabhu 20 Ben Ramalingam- Overseas Development Institute, United Kingdom. Jaideep Prabhu University of Cambridge, United Kingdom. “Innovation, development and COVID-19: Challenges, opportunities and ways forward.” OECD. 1 December 2020. Link: https://www.oecd.org/coronavirus/policy-responses/innovation-development-and-covid-19-challenges-opportunities-and-ways-forward-0c976158/ JV
Coronavirus (COVID-19) innovation:
AND
global coronavirus outbreak (SARS in 2002–04).
Medical innovation is crucial to prevent pandemics and mitigate economic harms during shut downs
Mulligan 21 Casey B. Mulligan– American economist and author. He is a Professor in Economics at the University of Chicago. “Economic activity and the value of medical innovation during a pandemic” Cambridge University Press. 9 June 2021. Link: https://www.cambridge.org/core/journals/journal-of-benefit-cost-analysis/article/economic-activity-and-the-value-of-medical-innovation-during-a-pandemic/864F8042F794D4417E64C643999C9280 JV
Medical innovation can
AND
for distributing them.
The risks associated with creating new drugs means that patents are key to biopharmaceutical innovation
Cockburn and Long 15 Iain Cockburn, Richard C. Shipley Professor of Management. Genia Long, senior advisor and part of analysis group. “The importance of patents to innovation: updates cross-industry comparison with biopharmaceuticals.” Taylor and Francis online, Volume 25, Issue 7, 2015. Published online: 30 April 2015. Link: https://www.tandfonline.com/doi/full/10.1517/13543776.2015.1040762 JV
Due to distinctive
AND
in other industries 7.
Pharma collapses without strong IP protections
Buckland 17 - Danny Buckland (award-winning journalist who writes about health, general features and news, shortlisted for the prestigious Mind Media Awards for his work covering mental health issues), April 26, 2017, “Patents are lifeblood of pharmas”, https://www.raconteur.net/legal/intellectual-property/patents-are-lifeblood-of-pharmas/ WJ
Pharmaceutical companies are
AND
without good IP.
Pandemics are a non-linear, existential risk-~--encompasses AND outweighs other threats. Empirically proven by historic epidemics such as the Black Death and Spanish flu
Pamlin and Armstrong 15, Dennis Pamlin, Executive Project Manager Global Risks, Global Challenges Foundation, and Stuart Armstrong, James Martin Research Fellow, Future of Humanity Institute, Oxford Martin School, University of Oxford, February 2015, “Global Challenges: 12 Risks that threaten human civilization: The case for a new risk category,” Global Challenges Foundation, p.30-93, https://api.globalchallenges.org/static/wp-content/uploads/12-Risks-with-infinite-impact.pdf Re DE EK
Global A pandemic
effective anti-pandemic solutions.